FIGURE 1.

Neuropsychiatric assessments at 1‐, 3‐, and 6‐month follow‐up in hyperbaric oxygen treated Alzheimer's disease (AD) and control AD patients. A and B, Changes of Mini‐Mental State Examination (MMSE) and Montreal Cognitive Assessment (MoCA) scores at 1‐, 3‐, and 6‐month follow‐up in AD after hyperbaric oxygen treatment versus control AD compared to baseline, respectively. Data were presented as mean ± standard deviation. Data of MMSE score in 1‐ and 6‐month follow‐up and MoCA score in 1‐, 3‐, and 6‐month follow‐up were analyzed by Mann‐Whitney test; data of MMSE score in 3 months was analyzed by t test. Sample size: n = 10 in 1‐month follow‐up, n = 9 in 3‐month follow‐up, and n = 11 in 6‐month follow‐up in control group; n = 42 in 1‐ and 3‐month follow‐up, n = 40 in 6‐month follow‐up in AD. ^* P < 0.05